1. Home
  2. GH vs HGV Comparison

GH vs HGV Comparison

Compare GH & HGV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GH
  • HGV
  • Stock Information
  • Founded
  • GH 2011
  • HGV 1992
  • Country
  • GH United States
  • HGV United States
  • Employees
  • GH N/A
  • HGV N/A
  • Industry
  • GH Medical Specialities
  • HGV Hotels/Resorts
  • Sector
  • GH Health Care
  • HGV Consumer Discretionary
  • Exchange
  • GH Nasdaq
  • HGV Nasdaq
  • Market Cap
  • GH 4.3B
  • HGV 4.1B
  • IPO Year
  • GH 2018
  • HGV N/A
  • Fundamental
  • Price
  • GH $31.83
  • HGV $39.28
  • Analyst Decision
  • GH Strong Buy
  • HGV Hold
  • Analyst Count
  • GH 14
  • HGV 8
  • Target Price
  • GH $39.93
  • HGV $45.00
  • AVG Volume (30 Days)
  • GH 1.6M
  • HGV 1.1M
  • Earning Date
  • GH 11-06-2024
  • HGV 11-07-2024
  • Dividend Yield
  • GH N/A
  • HGV N/A
  • EPS Growth
  • GH N/A
  • HGV N/A
  • EPS
  • GH N/A
  • HGV 0.89
  • Revenue
  • GH $692,256,000.00
  • HGV $4,238,000,000.00
  • Revenue This Year
  • GH $32.23
  • HGV $40.48
  • Revenue Next Year
  • GH $16.90
  • HGV $5.95
  • P/E Ratio
  • GH N/A
  • HGV $44.01
  • Revenue Growth
  • GH 29.20
  • HGV 18.38
  • 52 Week Low
  • GH $15.81
  • HGV $33.21
  • 52 Week High
  • GH $38.53
  • HGV $49.02
  • Technical
  • Relative Strength Index (RSI)
  • GH 45.64
  • HGV 43.04
  • Support Level
  • GH $34.20
  • HGV $37.74
  • Resistance Level
  • GH $36.24
  • HGV $40.91
  • Average True Range (ATR)
  • GH 1.70
  • HGV 1.09
  • MACD
  • GH -0.92
  • HGV -0.41
  • Stochastic Oscillator
  • GH 15.98
  • HGV 33.05

About GH Guardant Health Inc.

Guardant Health, Inc, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company offers Guardant360 LDT, a liquid biopsy test for treatment selection in advanced stage cancer, Guardant360 CDx, an FDA-approved companion diagnostic for several targeted therapies, and Guardant OMNI, a broader gene panel for immuno-oncology research. In 2021, Guardant launched Reveal, a tumor-agnostic molecular residual disease, or MRD, test. In 2022, the company launched a lab-developed test version of Shield, a liquid biopsy for colorectal cancer, or CRC, screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.

About HGV Hilton Grand Vacations Inc.

Hilton Grand Vacations Inc is a timeshare company engaged in developing, marketing, selling, managing, and operating timeshare resorts, timeshare plans, and ancillary reservation services, under the Hilton Grand Vacations brand. The company operates business in the following two segments: (i) Real estate sales and financing and (ii) Resort operations and club management. The majority of the company's revenue is earned through the Real estate sales and financing segment, which generates revenue from VOI sales, and Financing.

Share on Social Networks: